6-K

GSK SUBMITS AREXVY FOR ADULTS 18-49 AIR TO FDA

Company: GSK plc
Filed: July 14, 2025
Period of Report: July 14, 2025
Accession Number: 0001654954-25-008006

View Document ↗ View on SEC.gov ↗